Display options
Cite
Brzycki M, Richard R, Burwick N, et al. Autologous hematopoietic transplantation following COVID-19 infection. Clin Case Rep. 2021;9(3):1167-1170doi: 10.1002/ccr3.3712.
Brzycki, M., Richard, R., Burwick, N., Graf, S., O'Brien, C., Wu, D., & Chauncey, T. R. (2021). Autologous hematopoietic transplantation following COVID-19 infection. Clinical case reports, 9(3), 1167-1170. https://doi.org/10.1002/ccr3.3712
Brzycki, Marthilde, et al. "Autologous hematopoietic transplantation following COVID-19 infection." Clinical case reports vol. 9,3 (2021): 1167-1170. doi: https://doi.org/10.1002/ccr3.3712
Brzycki M, Richard R, Burwick N, Graf S, O'Brien C, Wu D, Chauncey TR. Autologous hematopoietic transplantation following COVID-19 infection. Clin Case Rep. 2021 Jan 03;9(3):1167-1170. doi: 10.1002/ccr3.3712. eCollection 2021 Mar. PMID: 33768803; PMCID: PMC7981617.
Copy Download .nbib Format: NLM
Share it on

Clin Case Rep. 2021 Jan 03;9(3):1167-1170. doi: 10.1002/ccr3.3712. eCollection 2021 Mar.

Autologous hematopoietic transplantation following COVID-19 infection.

Clinical case reports

Marthilde Brzycki, Robert Richard, Nicholas Burwick, Solomon Graf, Craig O'Brien, Daniel Wu, Thomas R Chauncey

Affiliations

  1. Marrow Transplant Unit VA Puget Sound Health Care System Seattle WA USA.
  2. Division of Hematology Department of Medicine University of Washington Seattle WA USA.
  3. Division of Medical Oncology Department of Medicine University of Washington Seattle WA USA.
  4. Clinical Research Division Fred Hutchinson Cancer Research Center Seattle WA USA.

PMID: 33768803 PMCID: PMC7981617 DOI: 10.1002/ccr3.3712

Abstract

Autologous hematopoietic cell transplantation following induction therapy is standard of care for most patients with newly diagnosed multiple myeloma (

© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Keywords: COVID‐19; autologous transplantation; multiple myeloma

Conflict of interest statement

The authors declare no competing financial interests. No research funding was associated with this report. The subject provided informed consent for treatment and correlative research.

References

  1. Clin Infect Dis. 2020 Nov 19;71(16):2027-2034 - PubMed
  2. Leukemia. 2020 Nov;34(11):3047-3049 - PubMed
  3. Neurology. 2020 Jun 2;94(22):959-969 - PubMed
  4. Br J Haematol. 1998 Jan;100(1):176-83 - PubMed
  5. J Hematol Oncol. 2020 Jul 14;13(1):94 - PubMed
  6. Front Neurol. 2020 May 29;11:565 - PubMed
  7. Int J Audiol. 2020 Dec;59(12):889-890 - PubMed
  8. Front Oncol. 2020 May 05;10:636 - PubMed
  9. Exp Hematol Oncol. 2020 Aug 25;9:21 - PubMed
  10. Leukemia. 2020 Oct;34(10):2809-2812 - PubMed
  11. Infect Dis Health. 2020 Aug;25(3):210-215 - PubMed
  12. Lancet Haematol. 2020 Oct;7(10):e737-e745 - PubMed
  13. Lancet. 2020 Jun 20;395(10241):1919-1926 - PubMed
  14. Neurology. 2020 Jul 14;95(2):77-84 - PubMed
  15. Front Immunol. 2020 Jun 05;11:1294 - PubMed
  16. Ann Oncol. 2020 Aug;31(8):1087-1088 - PubMed
  17. Blood Adv. 2020 Aug 11;4(15):3509-3519 - PubMed
  18. Br J Haematol. 2020 Jul;190(2):e83-e86 - PubMed
  19. N Engl J Med. 2017 Apr 6;376(14):1311-1320 - PubMed
  20. Transfus Apher Sci. 2020 Oct;59(5):102871 - PubMed

Publication Types